Chronic Hepatitis C Virus Infection: Developing Direct-Acting Antiviral Drugs for Treatment Guidance for Industry
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
November 7, 2017
May 4, 2020
930fbcbb-8430-4e5f-ad06-452dba6d03ff
Related Documents
Smallpox (Variola Virus) Infection: Developing Drugs for Treatment or Prevention Guidance for Industry
Guidance DocumentNovember 18, 2019Center for Drug Evaluation and Research
Recurrent Herpes Labialis: Developing Drugs for Treatment and Prevention
Guidance DocumentNovember 8, 2017Center for Drug Evaluation and Research
Vulvovaginal Candidiasis: Developing Drugs for Treatment
Guidance DocumentAugust 1, 2019Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox